Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia
NCT ID: NCT07065682
Last Updated: 2025-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1
84 participants
INTERVENTIONAL
2023-07-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate
NCT00880672
Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto
NCT00797394
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
NCT02058368
An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL
NCT01351987
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
NCT00062790
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dutasteride 0,5 mg/day + Aloe Vera Extract 380 mg/day
Aloevera + dutasteride
Dutasteride 0,5 mg/day + Aloe Vera Extract 380 mg/day
Dutasteride
Control
Dutasteride (0.5mg)
Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aloevera + dutasteride
Dutasteride 0,5 mg/day + Aloe Vera Extract 380 mg/day
Dutasteride (0.5mg)
Control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to participate to the study
Exclusion Criteria
* Previous prostatic surgery
* Patients with urinary retention
* Patients with BPH complications: urinary tract infections, urolithiasis, or hydroneprhosis
* Previously consumed alpha blocker or 5ARI in the last 6 months
* Have consumed aloe vera extract routinely
50 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitas Diponegoro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Achmad Rizky Herda Pratama
dr. Achmad Rizky Herda Pratama, Sp.U, S.H.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RSUD Karawang
Karawang, West Java, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Achmad Rizky Herda Pratama dr. Achmad Rizky Herda Pratama, Sp.U, S.H, Urologist
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Achmad Rizky Herda Pratama dr. Achmad Rizky Herda Pratama, Sp.U, S.H, Urologist
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Nugroho E, Azhar A, Gunadi E. Relationship between Prostate Volume and International Prostate Symptom Score (IPSS) Degree of Tamed Prostate Enlargement on Transabdominal Ultrasonography (TAUS) and Transrectal Ultrasonography (TRUS) Examination. Biomed J Indones. 2021;1(7):112-7
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22010119510006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.